EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Factors associated with tracheostomy‐associated infection treatment: A multicenter observational study

John M Morrison, Naoko Kono, Margaret Rush, Andrea Hahn, Catherine S Forster, Jonathan D Cogen, Joanna Thomson, Sarah Hofman DeYoung, Sowgand Bashiri, Wendy J Mack, Michael N Neely, Tamara D Simon und 2 weitere

Pediatric Pulmonology · 2024

DOI: 10.1002/ppul.27117 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von John M Morrison und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hospital Medicine, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA. Hauptthemen laut MEDLINE: Tracheostomy, Anti-Bacterial Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS, NHLBI NIH HHS, Gerber Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To characterize factors that influence the decision to treat suspected pediatric bacterial tracheostomy‐associated respiratory infections (bTRAINs; e.g., pneumonia, tracheitis).

Methods

We conducted a multicenter, prospective cohort study of children with pre‐existing tracheostomy hospitalized at six children's hospitals for a suspected bTRAIN (receipt of respiratory culture plus ≥1 doses of an antibiotic within 48 h). The primary predictor was respiratory culture growth categorized as Pseudomonas aeruginosa , P. aeruginosa + ≥1 other bacterium, other bacteria alone, or normal flora/no growth. Our primary outcome was bTRAIN treatment with a complete course of antibiotics as documented by the discharge team. We used logistic regression with generalized estimating equations to identify the association between our primary predictor and outcome and to identify demographic, clinical, and diagnostic testing factors associated with treatment.

Results

Of the 440 admissions among 289 patients meeting inclusion criteria, 307 (69.8%) had positive respiratory culture growth. Overall, 237 (53.9%) of admissions resulted in bTRAIN treatment. Relative to a negative culture, a culture positive for P. aeruginosa plus ≥1 other organism (adjusted odds ratio [aOR] 2.3; 95% confidence interval [CI] 1.02–5.0)] or ≥1 other organism alone (aOR: 2.8; 95% CI: 1.4–5.6)] was associated with treatment. Several clinical and diagnostic testing (respiratory Gram‐stain and chest radiograph) findings were also associated with treatment. Positive respiratory viral testing was associated with reduced odds of treatment (aOR: 0.5; 95% CI: 0.2–0.9).

Conclusions

Positive respiratory cultures as well as clinical indicators of acute illness and nonculture test results were associated with bTRAIN treatment. Clinicians may be more comfortable withholding antibiotics when a virus is identified during testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TracheostomyAnti-Bacterial AgentsHumansMaleFemaleProspective StudiesChild, PreschoolChildInfantPseudomonas aeruginosaRespiratory Tract InfectionsPseudomonas InfectionsAdolescentTracheitis

Stichwörter der Autor:innen

Pseudomonas aeruginosapediatricspneumoniatracheitistracheostomy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Pediatric Hospital Medicine, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
  • Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washingto, District Columbia, USA.
  • Division of Hospital Medicine, Children's National Hospital, Washington, District Columbia, USA.
  • Division of Infectious Diseases, Children's National Hospital, Washington, District Columbia, USA.

Förderung

  • AHRQ HHS
  • NHLBI NIH HHS
  • Gerber Foundation
  • the National Heart, Lung, and Blood Institute, National Institutes of Health
  • The Gerber Foundation and the Agency for Healthcare Research and Quality
  • National Heart, Lung, and Blood Institute
  • Agency for Healthcare Research and Quality

Zitieren

APA

Morrison, J. M., Kono, N., Rush, M., Hahn, A., Forster, C. S., Cogen, J. D., Thomson, J., DeYoung, S. H., Bashiri, S., Mack, W. J., Neely, M. N., Simon, T. D., Russell, C. J., & Pediatric Research in Inpatient Settings Network (2024). Factors associated with tracheostomy‐associated infection treatment: A multicenter observational study. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27117

Vancouver

Morrison JM, Kono N, Rush M, Hahn A, Forster CS, Cogen JD, et al. Factors associated with tracheostomy‐associated infection treatment: A multicenter observational study. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27117

BibTeX
@article{Morrison2024,
  author = {Morrison, John M and Kono, Naoko and Rush, Margaret and Hahn, Andrea and Forster, Catherine S and Cogen, Jonathan D and Thomson, Joanna and DeYoung, Sarah Hofman and Bashiri, Sowgand and Mack, Wendy J and Neely, Michael N and Simon, Tamara D and Russell, Christopher J and Pediatric Research in Inpatient Settings Network, Pediatric Research in Inpatient Settings Network},
  title = {Factors associated with tracheostomy‐associated infection treatment: A multicenter observational study},
  journal = {Pediatric Pulmonology},
  year = {2024},
  doi = {10.1002/ppul.27117}
}
Kostenlos starten →